Thermo Fisher Scientific (TMO) Invested Capital (2009 - 2026)

Thermo Fisher Scientific (TMO) has reported Invested Capital for 18 consecutive years, with $94.9 billion the latest figure, recorded in Q1 2026.

• Invested Capital for Q1 2026 came in at $94.9 billion, up 13.84% year-over-year; the trailing twelve-month figure through Mar 2026 was $94.9 billion (up 13.84% YoY), and the FY2025 annual result was $92.6 billion, up 14.84% from the prior year.
• Invested Capital was $94.9 billion for Q1 2026 at Thermo Fisher Scientific, up from $92.6 billion in the prior quarter.
• Over five years, Invested Capital peaked at $94.9 billion in Q1 2026 and troughed at $72.4 billion in Q3 2022.
• Average Invested Capital over 5 years is $81.5 billion, with a median of $80.9 billion recorded in 2024.
• Year-over-year, Invested Capital soared 37.91% in 2022 and decreased 1.02% in 2024.
• Over 5 years, Invested Capital stood at $78.3 billion in 2022, then gained by 4.01% to $81.5 billion in 2023, then decreased by 1.02% to $80.6 billion in 2024, then rose by 14.84% to $92.6 billion in 2025, then climbed by 2.48% to $94.9 billion in 2026.
• Per Business Quant data, the three most recent Invested Capital figures were $94.9 billion in Q1 2026, $92.6 billion in Q4 2025, and $86.5 billion in Q3 2025.